Published: May 5, 2026
Written by Klarity Editorial Team
Published: May 5, 2026

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can manage medications via telehealth, the short answer is: Yes — with some important caveats. Telehealth has become mainstream in psychiatry, but the rules around prescribing (especially controlled substances like Adderall or Xanax) vary by state and are still evolving at the federal level.
This guide breaks down what psychiatrists and PMHNPs can legally do when prescribing through telemedicine, how the rules differ between provider types, and what you need to know to stay compliant while building a sustainable telehealth practice.
The big question: Can you prescribe controlled substances via telehealth without an initial in-person visit?
Right now, yes — but it’s temporary. The DEA’s emergency telemedicine waiver (which suspended the Ryan Haight Act’s in-person exam requirement) has been extended through December 31, 2025. This means psychiatrists can currently prescribe Schedule II–V medications (stimulants for ADHD, benzodiazepines for anxiety, buprenorphine for opioid use disorder) to new patients via video visit, with no prior in-person exam required.
What happens after 2025? The DEA has proposed new permanent rules that could re-impose some restrictions — possibly requiring an in-person visit after an initial 30-day telemedicine prescription, or implementing a special telemedicine registration system. The final rules haven’t been published yet, so providers should monitor DEA announcements closely.
Practical takeaway: As of early 2026, you can initiate controlled substance prescribing via telehealth nationwide. Just be prepared to adapt if the DEA tightens the rules later this year.
While federal law sets the baseline, states add their own layers. Some states explicitly permit telehealth prescribing of controlled substances for psychiatric treatment; others have carved out restrictions for certain use cases (like chronic pain management).
Florida stands out for explicitly allowing controlled substance prescribing via telehealth for psychiatric disorders (Florida Statutes 456.47). If you’re treating ADHD, anxiety, or other mental health conditions, you can prescribe stimulants or benzodiazepines remotely to Florida patients — even though Florida restricts teleprescribing for chronic pain management.
New York recently updated its regulations (finalized in mid-2025) to align with federal telehealth allowances. The state removed its prior in-person exam requirement for controlled substances when federal law permits remote prescribing. New York psychiatrists can confidently prescribe controlled meds via telehealth under the current DEA waiver.
California permits prescribing via telemedicine as long as you conduct a ‘good faith exam’ — and a video visit qualifies. California law doesn’t distinguish between in-person and telehealth exams for prescribing authority. You must check California’s prescription monitoring database (CURES) before prescribing Schedule II–IV medications, but that’s a requirement for all prescribing, not just telehealth.
Texas allows telemedicine prescribing if the standard of care is met, but prohibits prescribing Schedule II opioids for chronic pain via telehealth (you need an in-person exam for that). However, psychiatric treatment is generally exempt — Texas psychiatrists can prescribe stimulants for ADHD or other psychiatric medications via video visit under current federal allowances. Texas also requires checking the state’s Prescription Monitoring Program before any controlled substance prescription.
Pennsylvania doesn’t add unique state-level telehealth prescribing restrictions beyond federal law, but the lack of comprehensive telehealth parity legislation means you should verify that your payer contracts cover telepsychiatry at the same rate as in-person visits.
Several states and Medicare now reimburse audio-only (phone) mental health visits to address the digital divide. Medicare covers certain psychiatric services via telephone at the same rate as video visits, and states like Massachusetts and Illinois require private payers to do the same. This can be useful for brief medication check-ins with patients who lack video access, though most initial evaluations should still be done via video to meet the standard of care.
The rules diverge sharply when you compare psychiatrists (MD/DO) to psychiatric nurse practitioners (PMHNPs).
If you’re a board-certified psychiatrist, you have unrestricted independent prescribing authority in all 50 states. You can prescribe any psychiatric medication, including all controlled substances, as long as you hold:
No collaborative agreements. No supervision requirements. No formulary restrictions.
The only limitations are specialty-specific (like REMS programs for clozapine) or federal rules (like the temporary DEA waiver for controlled substance prescribing via telehealth).
For psychiatric nurse practitioners, prescribing authority is entirely state-dependent. States fall into three categories:
1. Full Practice Authority States (~34 states as of 2025)
In these states, experienced PMHNPs can evaluate, diagnose, and prescribe medications (including controlled substances) independently, with no physician oversight required. Examples include:
2. Reduced Practice States
PMHNPs need a collaborative practice agreement with a physician to prescribe, but can practice at separate locations. The agreement typically requires:
Pennsylvania is a classic example: PMHNPs must maintain a collaborative agreement indefinitely (no path to independence). The physician must review a percentage of charts regularly, and the agreement must specify which medications the NP can prescribe.
3. Restricted Practice States
PMHNPs operate under continuous physician supervision or delegation. This includes:
Texas: All NP prescribing is delegated from a supervising physician. PMHNPs must have a Prescriptive Authority Agreement, and Texas law caps the supervising physician to overseeing no more than 7 NPs/PAs at once. Importantly, Texas NPs generally cannot prescribe Schedule II stimulants in outpatient settings (there’s a narrow exception for children with ADHD under specific conditions). A Texas PMHNP treating ADHD would typically have the supervising psychiatrist write the initial stimulant prescription.
Florida: Psychiatric NPs were excluded from Florida’s 2020 ‘autonomous practice’ law, which only applied to primary care NPs. PMHNPs in Florida must practice under a physician’s protocol. However, Florida law allows ‘psychiatric nurses’ (PMHNPs with 2+ years of psych experience under an MD) to prescribe psychotropic controlled substances in collaboration with a psychiatrist, exempt from the 7-day Schedule II limit that applies to other NPs.
In states requiring collaboration, finding a supervising psychiatrist can be a significant pain point — especially in underserved areas. Some psychiatrists charge fees to serve as collaborators (often $1,000–3,000/month), and states like Florida and Pennsylvania require the collaborator to be in the same specialty (a PMHNP needs a psychiatrist, not just any physician).
This creates both a financial burden and a practice limitation: you can’t start seeing patients until the agreement is signed, filed (if required by state boards), and periodically renewed.
Short answer: Yes, for mental health services.
Medicare has made most telehealth flexibilities for mental health permanent (with minor requirements like an in-person visit every 12 months for some patients, currently paused through 2025). Rates for common psychiatric medication management visits:
Important: Medicare reimburses PMHNPs at 85% of physician rates when billed under the NP’s own NPI. So a 99213 that pays a psychiatrist $95 would pay a PMHNP approximately $81.
Many states have enacted telehealth payment parity laws requiring private insurers to reimburse telehealth services at the same rate as in-person visits. Examples:
Texas has a coverage law but does not mandate payment parity — however, most major insurers voluntarily pay equal rates for tele-mental health given high demand.
Medicaid rates are generally lower than Medicare or commercial insurance but vary by state. Many state Medicaid programs have enhanced behavioral health reimbursement to address provider shortages. States like New York and Pennsylvania reimburse telepsychiatry at the same rate as in-person visits.
Traditional marketing channels for building a psychiatric practice are expensive and uncertain:
The platform alternative: Instead of gambling on marketing channels, platforms like Klarity Health operate on a pay-per-appointment model. You pay a standard listing fee per new patient lead — only when a qualified patient books with you. No upfront marketing spend. No wasted ad budget on clicks that don’t convert. No long SEO runway before seeing results.
The value props:
For most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the financial risk entirely.
You can build a robust telehealth practice across multiple states with relative ease:
Your pathway depends on where you practice:
In FPA states (New York after 3,600 hours, Illinois after 4,000 hours, California by 2026): You can practice similarly to a psychiatrist once you meet experience requirements. Focus on states where you already have or can easily obtain independent practice authority.
In reduced/restricted states (Texas, Florida, Pennsylvania): You’ll need to secure a collaborative agreement before you can start seeing patients. Some telehealth platforms provide collaborating physicians as part of their infrastructure, which can remove this barrier. Alternatively, budget $1,000–3,000/month for a private collaboration arrangement.
Reimbursement reality: Even with independent practice authority, you’ll likely be paid at 85% of physician rates by Medicare and some private payers. Factor this into your revenue projections.
Telehealth prescribing in psychiatry is not only legal but increasingly well-supported by reimbursement parity and flexible regulations. Psychiatrists can prescribe virtually any psychiatric medication remotely under current federal allowances, while PMHNPs’ authority depends heavily on state scope-of-practice laws.
The economics favor telehealth: you can see more patients, eliminate commute time, reduce no-shows, and expand your geographic reach — all while getting paid the same (or nearly the same) as in-person visits.
For providers willing to navigate licensing requirements and stay current on DEA rules, telehealth offers a sustainable, scalable path to building a thriving psychiatric practice.
Ready to skip the marketing gamble and get matched with qualified patients? Platforms like Klarity Health provide pre-screened patient flow, telehealth infrastructure, and a pay-per-appointment model that guarantees ROI. Explore joining Klarity’s provider network to start seeing patients without the upfront marketing investment.
Q: Can I prescribe Adderall or other stimulants via telehealth?
Yes, under current federal DEA waivers (extended through December 31, 2025), psychiatrists can prescribe Schedule II stimulants to new patients via video visit without a prior in-person exam. State rules may add nuances — for example, Texas NPs generally cannot prescribe Schedule II stimulants, but Texas psychiatrists can. Monitor DEA announcements for permanent rule changes expected in 2025.
Q: Do I need to be licensed in every state where I see telehealth patients?
Yes. You must hold a valid medical or nursing license in the state where the patient is physically located during the visit. The Interstate Medical Licensure Compact (IMLC) can expedite obtaining multiple state licenses for physicians; Texas, Pennsylvania, and Illinois are IMLC members. New York, Florida, and California are not.
Q: How does reimbursement work if I’m a PMHNP doing telehealth?
Medicare pays PMHNPs at 85% of physician rates when you bill under your own NPI. Many private insurers follow similar policies. Some states have equal reimbursement laws that require parity regardless of provider type. In practice, expect slightly lower per-visit revenue as an NP compared to an MD unless you’re in a state with mandated parity.
Q: What if I want to practice across state lines but don’t want the hassle of getting multiple licenses?
Some telehealth platforms handle credentialing and provide access to patients in states where they already have provider networks. Alternatively, focus on high-demand states where you already have (or can easily obtain) licensure. Many psychiatric providers start with 2–3 states and expand as demand grows.
Q: Are there any psychiatric medications I can’t prescribe via telehealth?
Under current rules, there are no psychiatric medication classes categorically banned from telehealth prescribing. However, some states restrict certain uses (e.g., Texas prohibits teleprescribing Schedule II opioids for chronic pain). Medications requiring special monitoring (like clozapine) can be prescribed via telehealth as long as you coordinate lab work with the patient’s local providers.
Q: What happens to telehealth prescribing rules when the DEA waiver expires?
The DEA is expected to publish permanent rules by late 2025. Proposed rules suggest possible in-person visit requirements after an initial telemedicine prescription, or a special telemedicine DEA registration. Until final rules are published, providers should stay informed through professional associations and be prepared to adjust practices if requirements change.
Texas Board of Nursing – APRN Practice FAQ. bon.texas.gov. Revised 2021. https://www.bon.texas.gov/faqpracticeaprn.asp.html
California Board of Registered Nursing – AB 890 Implementation. rn.ca.gov. Updated November 2023. https://www.rn.ca.gov/practice/ab890.shtml
Florida Senate – Chapter 464.012, Florida Statutes (2024): Advanced Practice Registered Nursing. flsenate.gov. https://www.flsenate.gov/laws/statutes/2024/464.012
National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates After the Pandemic Era.’ August 15, 2025. https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026 Update].’ 2026. https://therathink.com/insurance-reimbursement-rates-for-psychiatrists/
Find the right provider for your needs — select your state to find expert care near you.